Literature DB >> 18080173

HNF4alpha is a crucial modulator of the cholesterol-dependent regulation of NPC1L1.

Yuki Iwayanagi1, Tappei Takada, Hiroshi Suzuki.   

Abstract

PURPOSE: Niemann-Pick C1-like 1 (NPC1L1) has been identified as a target of ezetimibe and found to be responsible for intestinal cholesterol absorption. Although, it was recently demonstrated that sterol responsive element binding protein 2 (SREBP2) is responsible for the cholesterol-dependent down-regulation of NPC1L1, the molecular mechanism of NPC1L1 expression is not fully understood. In the present study, we examined the involvement of hepatocyte nuclear factor 4alpha (HNF4alpha), a key modulator of lipid metabolism, in the transcriptional regulation of human NPC1L1 gene.
METHODS: Reporter gene assays and EMSAs were performed using human NPC1L1 promoter constructs and the effect of siHNF4alpha was examined.
RESULTS: Transfection of SREBP2 induced the transcriptional activities of NPC1L1 and additional transfection of HNF4alpha results in a marked stimulation of the activities. Studies with deletion mutants indicated that important elements are located within 264 nt upstream in the human NPC1L1 promoter. In addition, studies with mutations in putative binding sites of HNF4alpha indicated the existence of binding sites in -209 to -197 and -52 to -40. Moreover, HNF4alpha knockdown resulted in the reduced expression and regulation by cholesterol.
CONCLUSIONS: It is concluded that HNF4alpha plays a crucial role in the expression and regulation of human NPC1L1 gene.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18080173     DOI: 10.1007/s11095-007-9496-9

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  28 in total

1.  Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption.

Authors:  Scott W Altmann; Harry R Davis; Li-Ji Zhu; Xiaorui Yao; Lizbeth M Hoos; Glen Tetzloff; Sai Prasad N Iyer; Maureen Maguire; Andrei Golovko; Ming Zeng; Luquan Wang; Nicholas Murgolo; Michael P Graziano
Journal:  Science       Date:  2004-02-20       Impact factor: 47.728

2.  Ezetimibe (Zetia): a new type of lipid-lowering agent.

Authors:  Jigna Patel; Valerie Sheehan; Cheryle Gurk-Turner
Journal:  Proc (Bayl Univ Med Cent)       Date:  2003-07

3.  Niemann-Pick C1 like 1 gene expression is down-regulated by LXR activators in the intestine.

Authors:  Caroline Duval; Véronique Touche; Anne Tailleux; Jean-Charles Fruchart; Catherine Fievet; Véronique Clavey; Bart Staels; Sophie Lestavel
Journal:  Biochem Biophys Res Commun       Date:  2006-01-05       Impact factor: 3.575

4.  LXR alpha transactivates mouse organic solute transporter alpha and beta via IR-1 elements shared with FXR.

Authors:  Masae Okuwaki; Tappei Takada; Yuki Iwayanagi; Saori Koh; Yoshiaki Kariya; Hiroshi Fujii; Hiroshi Suzuki
Journal:  Pharm Res       Date:  2006-12-20       Impact factor: 4.200

5.  The cholesterol absorption inhibitor, ezetimibe, decreases diet-induced hypercholesterolemia in monkeys.

Authors:  M van Heek; D S Compton; H R Davis
Journal:  Eur J Pharmacol       Date:  2001-03-09       Impact factor: 4.432

6.  The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1).

Authors:  Margarita Garcia-Calvo; JeanMarie Lisnock; Herbert G Bull; Brian E Hawes; Duane A Burnett; Matthew P Braun; James H Crona; Harry R Davis; Dennis C Dean; Patricia A Detmers; Michael P Graziano; Meredith Hughes; D Euan Macintyre; Anthony Ogawa; Kim A O'neill; Sai Prasad N Iyer; Diane E Shevell; Marsha M Smith; Yui S Tang; Amanda M Makarewicz; Feroze Ujjainwalla; Scott W Altmann; Kevin T Chapman; Nancy A Thornberry
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-31       Impact factor: 11.205

7.  Cooperative interaction between hepatocyte nuclear factor 4 alpha and GATA transcription factors regulates ATP-binding cassette sterol transporters ABCG5 and ABCG8.

Authors:  Koichi Sumi; Toshiya Tanaka; Aoi Uchida; Kenta Magoori; Yasuyo Urashima; Riuko Ohashi; Hiroto Ohguchi; Masashi Okamura; Hiromi Kudo; Kenji Daigo; Takashi Maejima; Noriaki Kojima; Iori Sakakibara; Shuying Jiang; Go Hasegawa; Insook Kim; Timothy F Osborne; Makoto Naito; Frank J Gonzalez; Takao Hamakubo; Tatsuhiko Kodama; Juro Sakai
Journal:  Mol Cell Biol       Date:  2007-04-02       Impact factor: 4.272

8.  Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe.

Authors:  Ryan E Temel; Weiqing Tang; Yinyan Ma; Lawrence L Rudel; Mark C Willingham; Yiannis A Ioannou; Joanna P Davies; Lisa-Mari Nilsson; Liqing Yu
Journal:  J Clin Invest       Date:  2007-07       Impact factor: 14.808

9.  Messenger RNA levels of genes involved in dysregulation of postprandial lipoproteins in type 2 diabetes: the role of Niemann-Pick C1-like 1, ATP-binding cassette, transporters G5 and G8, and of microsomal triglyceride transfer protein.

Authors:  S Lally; C Y Tan; D Owens; G H Tomkin
Journal:  Diabetologia       Date:  2006-03-04       Impact factor: 10.122

10.  Regulation of hepatic fasting response by PPARgamma coactivator-1alpha (PGC-1): requirement for hepatocyte nuclear factor 4alpha in gluconeogenesis.

Authors:  James Rhee; Yusuke Inoue; J Cliff Yoon; Pere Puigserver; Melina Fan; Frank J Gonzalez; Bruce M Spiegelman
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-21       Impact factor: 11.205

View more
  25 in total

1.  Opposing Gatekeepers of Apical Sterol Transport: Niemann-Pick C1-Like 1 (NPC1L1) and ATP-Binding Cassette Transporters G5 and G8 (ABCG5/ABCG8).

Authors:  J Mark Brown; Liqing Yu
Journal:  Immunol Endocr Metab Agents Med Chem       Date:  2009-03

2.  Hepatocyte nuclear factor 4α and downstream secreted phospholipase A2 GXIIB regulate production of infectious hepatitis C virus.

Authors:  Xinlei Li; Hanfang Jiang; Linbing Qu; Wenxia Yao; Hua Cai; Ling Chen; Tao Peng
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

Review 3.  Protein mediators of sterol transport across intestinal brush border membrane.

Authors:  J Mark Brown; Liqing Yu
Journal:  Subcell Biochem       Date:  2010

4.  Atorvastatin increases intestinal expression of NPC1L1 in hyperlipidemic men.

Authors:  André J Tremblay; Benoît Lamarche; Valéry Lemelin; Lizbeth Hoos; Suzanne Benjannet; Nabil G Seidah; Harry R Davis; Patrick Couture
Journal:  J Lipid Res       Date:  2010-12-01       Impact factor: 5.922

5.  Epigenetic modulation of intestinal cholesterol transporter Niemann-Pick C1-like 1 (NPC1L1) gene expression by DNA methylation.

Authors:  Pooja Malhotra; Vinay Soni; Anoop Kumar; Arivarasu N Anbazhagan; Amish Dudeja; Seema Saksena; Ravinder K Gill; Pradeep K Dudeja; Waddah A Alrefai
Journal:  J Biol Chem       Date:  2014-06-05       Impact factor: 5.157

6.  Small Heterodimer Partner and Fibroblast Growth Factor 19 Inhibit Expression of NPC1L1 in Mouse Intestine and Cholesterol Absorption.

Authors:  Young-Chae Kim; Sangwon Byun; Sunmi Seok; Grace Guo; H Eric Xu; Byron Kemper; Jongsook Kim Kemper
Journal:  Gastroenterology       Date:  2018-12-03       Impact factor: 22.682

7.  HNF1alpha and SREBP2 are important regulators of NPC1L1 in human liver.

Authors:  Camilla Pramfalk; Zhao-Yan Jiang; Qu Cai; Hai Hu; Sheng-Dao Zhang; Tian-Quan Han; Mats Eriksson; Paolo Parini
Journal:  J Lipid Res       Date:  2010-06       Impact factor: 5.922

8.  Curcumin inhibits cholesterol uptake in Caco-2 cells by down-regulation of NPC1L1 expression.

Authors:  Dan Feng; Lena Ohlsson; Rui-Dong Duan
Journal:  Lipids Health Dis       Date:  2010-04-19       Impact factor: 3.876

9.  FIC1-mediated stimulation of FXR activity is decreased with PFIC1 mutations in HepG2 cells.

Authors:  Saori Koh; Tappei Takada; Ikuya Kukuu; Hiroshi Suzuki
Journal:  J Gastroenterol       Date:  2009-04-21       Impact factor: 7.527

Review 10.  Bile formation and secretion.

Authors:  James L Boyer
Journal:  Compr Physiol       Date:  2013-07       Impact factor: 9.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.